tradingkey.logo
tradingkey.logo
Search

Protara Therapeutics Inc

TARA
Add to Watchlist
3.350USD
-0.190-5.37%
Close 09-24 16:00(ET)
188.27MMarket Cap
LossP/E TTM

TARA Financials

See Protara Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
188.27M
Dividend TTM
0.00
P/E TTM
-2.46
EPS TTM
-1.36
Revenue
--
Net Profit
-44.60M
ROE
-37.27%
ROA
-35.12%

Protara Therapeutics Inc Earnings Date

Latest Release
Aug 11, 2026
EPS / Forecast
-0.36/-0.33
Revenue / Forecast
--/0.00

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
-0.36%-0.36
-5.59%-0.31
19.56%-0.38
37.58%-0.31
21.01%-0.35
69.87%-0.29
48.07%-0.47
42.18%-0.50
55.14%-0.45
-21.41%-0.97
74.00%-0.90
---0.87
---1.00
---0.80
---3.46
---2.40
----
----
----
----
Net Profit
-44.84%-21.67M
-49.25%-17.78M
-35.54%-17.31M
-18.17%-13.26M
-57.26%-14.96M
-7.38%-11.91M
-24.93%-12.77M
-13.78%-11.22M
15.77%-9.51M
-22.66%-11.10M
73.77%-10.22M
-28.20%-9.86M
-32.26%-11.29M
15.90%-9.04M
-280.98%-38.97M
28.64%-7.69M
33.20%-8.54M
20.13%-10.76M
-16.13%-10.23M
-35.22%-10.78M
Debt to assets ratio
----
----
----
----
----
----
----
----
----
----
----
----
--0.00%
--0.00%
--0.00%
--0.00%
----
----
----
----
Operating profit
-40.62%-23.32M
-38.98%-19.63M
-33.31%-19.08M
-19.71%-14.76M
-55.58%-16.59M
-19.18%-14.12M
-29.63%-14.31M
-15.23%-12.33M
12.18%-10.66M
-21.77%-11.85M
-10.50%-11.04M
-34.19%-10.70M
-39.46%-12.14M
10.50%-9.73M
2.87%-9.99M
26.37%-7.97M
31.95%-8.71M
19.93%-10.87M
-14.86%-10.29M
-34.33%-10.83M
Net Profit
-44.84%-21.67M
-49.25%-17.78M
-35.54%-17.31M
-18.17%-13.26M
-57.26%-14.96M
-7.38%-11.91M
-24.93%-12.77M
-13.78%-11.22M
15.77%-9.51M
-22.66%-11.10M
73.77%-10.22M
-28.20%-9.86M
-32.26%-11.29M
15.90%-9.04M
-280.98%-38.97M
28.64%-7.69M
33.20%-8.54M
20.13%-10.76M
-16.13%-10.23M
-35.22%-10.78M
Current assets
16.84%146.15M
10.64%140.00M
-7.35%159.50M
59.43%135.64M
35.65%125.09M
118.49%126.53M
150.57%172.16M
9.34%85.08M
9.43%92.21M
-38.79%57.91M
-20.25%68.70M
-21.14%77.81M
-16.64%84.27M
4.33%94.62M
-7.48%86.15M
3.11%98.67M
15.11%101.09M
3.41%90.69M
-45.05%93.11M
-42.74%95.69M
Total current liabilities
36.45%13.32M
27.13%8.92M
-0.20%10.94M
14.66%9.91M
72.82%9.76M
27.58%7.02M
78.26%10.96M
27.56%8.64M
14.52%5.65M
-14.18%5.50M
7.13%6.15M
82.57%6.78M
41.20%4.93M
124.05%6.41M
33.55%5.74M
0.62%3.71M
-4.77%3.49M
-13.64%2.86M
47.44%4.30M
-5.11%3.69M
Total assets
12.21%176.09M
13.86%191.92M
15.44%209.47M
53.72%144.64M
54.39%156.93M
147.39%168.56M
129.82%181.45M
6.36%94.09M
6.84%101.65M
-35.97%68.13M
-30.31%78.95M
-40.46%88.47M
-38.57%95.14M
-34.01%106.41M
-34.36%113.29M
-17.77%148.59M
-18.00%154.88M
-16.19%161.26M
-15.04%172.60M
-9.16%180.70M
Total liabilities
18.16%14.78M
6.35%10.71M
-8.83%13.06M
0.37%12.35M
30.35%12.51M
3.57%10.07M
34.68%14.32M
6.85%12.30M
-3.22%9.60M
-16.40%9.73M
-5.12%10.63M
22.29%11.51M
5.20%9.92M
29.00%11.64M
4.91%11.21M
-8.53%9.41M
-10.12%9.43M
110.43%9.02M
172.92%10.68M
140.36%10.29M
Total equity
11.69%161.31M
14.34%181.21M
17.52%196.41M
61.74%132.29M
56.90%144.42M
171.35%158.48M
144.63%167.13M
6.28%81.79M
8.01%92.05M
-38.37%58.41M
-33.07%68.32M
-44.71%76.96M
-41.41%85.22M
-37.75%94.77M
-36.95%102.08M
-18.33%139.18M
-18.47%145.46M
-19.08%152.24M
-18.74%161.91M
-12.44%170.41M
Net operating income
-25.62%-15.39M
-45.06%-21.34M
-82.10%-16.95M
-47.64%-12.45M
-59.36%-12.25M
-41.76%-14.71M
-6.99%-9.31M
-28.55%-8.43M
18.29%-7.69M
19.47%-10.38M
-73.10%-8.70M
-22.70%-6.56M
-83.64%-9.41M
-17.58%-12.89M
27.23%-5.03M
13.77%-5.35M
45.93%-5.12M
8.05%-10.96M
-2.09%-6.91M
-64.83%-6.20M
Net investment
137.20%17.75M
74.77%-14.72M
-219.59%-26.91M
77.86%-6.51M
-1720.48%-47.72M
-352.61%-58.35M
54.98%22.50M
-560.80%-29.39M
-86.82%2.94M
134.28%23.10M
179.14%14.52M
-66.52%6.38M
65.54%22.35M
1223.49%9.86M
-1071.15%-18.34M
17701.87%19.05M
795.62%13.50M
100.76%745.00K
470.10%1.89M
180.97%107.00K
Net financing
-425.00%-26.00K
-33.87%1.14M
-17.26%80.96M
--13.00K
-99.98%8.00K
2376.32%1.73M
--97.85M
100.00%0.00
--42.09M
-18.75%-76.00K
--0.00
-50.00%-27.00K
--0.00
11.11%-64.00K
--0.00
---18.00K
--0.00
68.42%-72.00K
-100.00%0.00
-100.00%0.00

Revenue

By Business

Period:
No Data

By Region

Period:
No Data

FAQs

What are the current assets of Protara Therapeutics Inc?

According to Protara Therapeutics Inc's FY2025 earnings report, its current assets were 159.50M, with a year-on-year change of -7.35.

What are the total assets of Protara Therapeutics Inc?

According to Protara Therapeutics Inc's FY2025 earnings report, its total assets of Protara Therapeutics Inc were 209.47M, with a year-on-year change of 15.44.

What are the total liabilities of Protara Therapeutics Inc?

According to Protara Therapeutics Inc's FY2025 earnings report, its total liabilities of Protara Therapeutics Inc were 13.06M, with a year-on-year change of -8.83.

What is the total equity of Protara Therapeutics Inc?

According to Protara Therapeutics Inc's FY2025 earnings report, its total equity of Protara Therapeutics Inc was 196.41M, with a year-on-year change of 17.52.

What is the net operating income of Protara Therapeutics Inc?

According to Protara Therapeutics Inc's FY2025 earnings report, its net operating income of Protara Therapeutics Inc was -64.55M, with a year-on-year change of -31.32.

What is the net investment of Protara Therapeutics Inc?

According to Protara Therapeutics Inc's FY2025 earnings report, its net investment of Protara Therapeutics Inc was -139.49M, with a year-on-year change of -828.22.

What is the net financing of Protara Therapeutics Inc?

According to Protara Therapeutics Inc's FY2025 earnings report, its net financing of Protara Therapeutics Inc was 82.72M, with a year-on-year change of -40.86.

What is the Earnings Per Share (EPS) of Protara Therapeutics Inc?

According to Protara Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.34, with a year-on-year change of 38.08.

What is the net income of Protara Therapeutics Inc?

According to Protara Therapeutics Inc's FY2025 earnings report, its net income was -57.44M, with a year-on-year change of -28.80.

What is the Return on Equity (ROE) of Protara Therapeutics Inc?

According to Protara Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -31.60, with a year-on-year change of 16.58.

What is the Return on Assets (ROA) of Protara Therapeutics Inc?

According to Protara Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -29.39, with a year-on-year change of 14.20.

What is the operating profit of Protara Therapeutics Inc?

According to Protara Therapeutics Inc's FY2025 earnings report, its operating profit was -64.55M, with a year-on-year change of -31.32.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.